date,title,source
Dec-18-18,TLC Announces Phase I/II Full Enrollment in Hernia Repair Surgery and Phase II Initiation in Bunionectomy of TLC590 for Postsurgical Pain,GlobeNewswire
Jan-22-19,EMA Grants Orphan Drug Designation to TLC178 for the Treatment of Soft Tissue Sarcoma,GlobeNewswire
Jan-25-19,"TLC Appoints George Spencer-Green, MD, MS, as Chief Medical Officer",GlobeNewswire
Mar-11-19,TLC Reports Positive Top-Line Results from Phase I/II Clinical Trial of TLC590 for Postsurgical Pain,GlobeNewswire
Mar-18-19,TLC Announces First Patient Dosed in Phase II Trial of TLC590 for Postsurgical Pain Management following Bunionectomy,GlobeNewswire
